Key result
Sapovirus GI.1 was the predominant strain (60%) among successfully amplified samples from children with diarrhoea in rural South Africa, followed by SV-GII.1 (20%).
Why the study?
Viral diarrhoea is a concern in acute gastroenteritis among children younger than 5 years of age, and sapovirus has emerged as a causative agent worldwide.
Observational (n=25)
Sapovirus GI.1 is the predominant strain among children with sapovirus-associated diarrhoea in rural South Africa based on partial VP1 region analysis.
May inform regional sapovirus diagnostics in pediatric diarrhea; extends African strain data but leaves broader applicability open.
Background. Viral diarrhoea is a concern in acute gastroenteritis cases among children younger than 5 years of age. Sapovirus has been noted as an emerging causative agent of acute gastroenteritis worldwide. Objective/Study Design. The aim of this study was to characterize human sapoviruses targeting the VP1 (NVR and N-terminal) region. Twenty-five samples were randomly selected from 40 sapovirus-positive samples previously detected and analyzed for the VP1 region using the One-Step RT-PCR assay. The PCR products were subjected to Sanger sequencing analysis. Results. The polyprotein segment (NVR and N-terminal) was successfully amplified from 10/25 samples. Sapovirus GI.1 was the most predominant strain (6/10; 60%), followed by SV-GII.1 (2/10; 20%) and 10% of each GI.3 and GII.3. Conclusion. Through the partial analysis of the VP1 region, this study provides more data to add on the human sapovirus genetic characterization of circulating strains in South Africa, with the proposition of further analysis of sapovirus VP1 fragments for the viral structure and function.
No takes yet. Share an insight, caveat, or question.
Magwalivha et al. (2022) conducted an observational in Diarrhoea (n=25). Sapovirus was evaluated on Sapovirus strain characterization. Sapovirus GI.1 was the predominant strain (60%) among successfully amplified samples from children with diarrhoea in rural South Africa, followed by SV-GII.1 (20%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: